Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AAWW
651
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $13.3M | 0.01% |
131,829
-44,303
| -25% | -$4.44M |
|
652
Colgate-Palmolive
CL
$73.3B
| $13.2M | 0.01% |
167,856
-21,652
| -11% | -$1.62M |
|
653
C.H. Robinson
CHRW
$17.3B
| $13.1M | 0.01% |
143,510
+107,508
| +299% | +$10.2M |
|
654
Truist Financial
TFC
$63.5B
| $13.1M | 0.01% |
304,890
-264,208
| -46% | -$11.6M |
|
655
Burford Capital
BUR
$922M
| $13.1M | 0.01% |
1,634,403
-1,608,983
| -50% | -$13.3M |
|
656
Blackrock
BLK
$170B
| $13M | 0.01% |
18,372
-17,980
| -49% | -$12M |
|
657
Grab
GRAB
$13.9B
| $13M | 0.01% |
4,036,413
-80,081
| -2% | -$230K |
|
658
Philip Morris
PM
$299B
| $13M | 0.01% |
128,291
-204,329
| -61% | -$19.3M |
|
|
ETNB
659
DELISTED
89bio
ETNB
| $13M | 0.01% |
1,019,379
-556,605
| -35% | -$5.01M |
|
660
Republic Services
RSG
$65B
| $12.9M | 0.01% |
100,256
+51,366
| +105% | +$6.85M |
|
|
ENFN
661
DELISTED
Enfusion, Inc.
ENFN
| $12.9M | 0.01% |
1,336,823
-1,336,823
| -50% | -$15.1M |
|
662
Oshkosh
OSK
$8.82B
| $12.9M | 0.01% |
146,066
+121,144
| +486% | +$10.4M |
|
|
FORG
663
DELISTED
ForgeRock, Inc.
FORG
| $12.8M | 0.01% |
+563,124
| New | +$12.3M |
|
|
OKLO
664
Oklo
OKLO
$7.15B
| $12.7M | 0.01% |
+1,281,220
| New | +$12.6M |
|
665
Edgewise Therapeutics
EWTX
$4.42B
| $12.7M | 0.01% |
1,419,869
-1,666,143
| -54% | -$15.6M |
|
|
LHCG
666
DELISTED
LHC Group LLC
LHCG
| $12.7M | 0.01% |
78,203
-39,193
| -33% | -$6.47M |
|
667
VeriSign
VRSN
$25.9B
| $12.6M | 0.01% |
61,566
+36,208
| +143% | +$6.94M |
|
668
MongoDB
MDB
$26.2B
| $12.6M | 0.01% |
64,152
-211,854
| -77% | -$37.7M |
|
669
Certara
CERT
$1.21B
| $12.6M | 0.01% |
781,703
-254,481
| -25% | -$3.69M |
|
670
Treace Medical Concepts
TMCI
$284M
| $12.5M | 0.01% |
543,280
-785,812
| -59% | -$18.1M |
|
671
Duke Energy
DUK
$98.4B
| $12.5M | 0.01% |
121,170
-78,338
| -39% | -$7.52M |
|
672
IDEAYA Biosciences
IDYA
$3.5B
| $12.4M | 0.01% |
683,977
-678,377
| -50% | -$11.4M |
|
673
Vor Biopharma
VOR
$1.18B
| $12.4M | 0.01% |
+93,023
| New | +$9.2M |
|
|
SRDX
674
DELISTED
Surmodics
SRDX
| $12.3M | 0.01% |
361,735
-382,173
| -51% | -$12.8M |
|
675
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.7B
| $12.3M | 0.01% |
210,866
+42,730
| +25% | +$2.5M |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.